Anti-C1q antibodies in systemic lupus erythematosus

Lupus

Volumn 24, Issue 1, 2015, Pages 42-49

  Orbai, A M ^a   Truedsson, L ^b   Sturfelt, G ^c   Nived, O ^c   Fang, H ^a   Alarcon G S ^d   Gordon, C ^e   Merrill, J T ^f   Fortin, P R ^g   Bruce, I N ^h,i   Isenberg, D A ^j   Wallace, D J ^k   Ramsey Goldman, R ^l   Bae, S C ^m   Hanly, J G ⁿ   Sanchez Guerrero, J ^o   Clarke, A E ^p   Aranow, C B ^q   Manzi, S ^r   Urowitz, M B ^s   Gladman, D D ^s   Kalunian, K C ^t   Costner, M I ^u   Werth, V P ^v   Zoma, A ^w   Bernatsky, S ^p   Ruiz Irastorza, G ^x   Khamashta, M A ^y   Jacobsen, S ^z   Buyon, J P ^aa   Maddison, P ^ab   Dooley, M A ^ac   Van Vollenhoven, R F ^ad   Ginzler, E ^ae   Stoll, T ^af   Peschken, C ^ag   Jorizzo, J L ^ah   Callen, J P ^ai   Lim, S S ^aj   Fessler, B J ^d   Inanc, M ^ak   Kamen, D L ^al   Rahman, A ⁱ   Steinsson, K ^am   Franks, A G ^aa   Sigler, L ^a   Hameed, S ^a   Pham, N ^a   Brey, R ^an   Weisman, M H ^ao   McGwin, G ^d   Magder, L S ^ap   Petri, M ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^g LAVAL UNIVERSITY   (Canada)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^j Centre for Rheumatology Research Division of Medicine   (United Kingdom)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m Hanyang University Hospital for Rheumatic Diseases   (South Korea)

ⁿ DALHOUSIE UNIVERSITY   (Canada)

^o UNIVERSITY HEALTH NETWORK   (Canada)

^p MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^q FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^r ALLEGHENY GENERAL HOSPITAL   (United States)

^s TORONTO WESTERN HOSPITAL   (Canada)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u North Dallas Dermatology Associates   (United States)

^v UNIVERSITY OF PENNSYLVANIA   (United States)

^w HAIRMYRES HOSPITAL   (United Kingdom)

^x UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^y ST THOMAS HOSPITAL   (United Kingdom)

^z University of Copenhagen   (Denmark)

^aa NEW YORK UNIVERSITY   (United States)

^ab YSBYTY GWYNEDD   (United Kingdom)

^ac UNIVERSITY OF NORTH CAROLINA   (United States)

^ad KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ae SUNY DOWNSTATE MEDICAL CENTER   (United States)

^af Kantonsspital Schaffhausen   (Switzerland)

^ag UNIVERSITY OF MANITOBA   (Canada)

^ah WAKE FOREST UNIVERSITY   (United States)

^ai UNIVERSITY OF LOUISVILLE   (United States)

^aj EMORY UNIVERSITY   (United States)

^ak ISTANBUL UNIVERSITY   (Turkey)

^al MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^am LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^an UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^ao CEDARS SINAI MEDICAL CENTER   (United States)

^ap UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Anti dsDNA antibodies; renal lupus; systemic lupus erythematosus

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q ANTIBODY; IMMUNOGLOBULIN G; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1Q; DNA;

ADULT; ARTHRITIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HUMAN; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MULTICENTER STUDY; PERICARDITIS; PHOTOSENSITIVITY; PLEURISY; PROTEINURIA; PSYCHOSIS; RASH; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; DEFICIENCY; ETHNOLOGY; IMMUNOLOGY; MIDDLE AGED; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADULT; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; COMPLEMENT C1Q; COMPLEMENT SYSTEM PROTEINS; CROSS-SECTIONAL STUDIES; DNA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROTEINURIA; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84918547572     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314547791     Document Type: Article

References (34)

1. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology. 2002 ; 205: 395-406
2. Sturfelt G, Truedsson L. Complement in the immunopathogenesis of rheumatic disease. Nat Rev Rheumatol. 2012 ; 8: 458-468
3. Schejbel L, Skattum L, Hagelberg S, et al. Molecular basis of hereditary C1q deficiency - revisited: Identification of several novel disease-causing mutations. Genes Immun. 2011 ; 12: 626-634
4. Lood C, Gullstrand B, Truedsson L, et al. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: A novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 2009 ; 60: 3081-3090
5. Sturfelt G, Johnson U, Sjöholm AG. Sequential studies of complement activation in systemic lupus erythematosus. Scand J Rheumatol. 1985 ; 14: 184-196
6. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum. 2006 ; 54: 421-432
7. Nived O, Hallengren CS, Alm P, Jönsen A, Sturfelt G, Bengtsson A. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area in Southern Sweden: The clinical utility of the ACR renal response criteria and predictors for renal outcome. Scan J Rheumatol. 2013 ; 42: 383-389
8. Mannik M, Wener MH. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 1997 ; 40: 1504-1511
9. Sjöwall C, Olin AI, Skogh T, Wettero J, Morgelin M, Nived O, et al. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Autoimmunity. 2013 ; 46 (3). 205-214
10. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis. 2005 ; 64: 444-448
11. Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis. 1993 ; 52: 851-856
12. Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant. 2006 ; 21: 3115-3121
13. Fang QY, Yu F, Tan Y, et al. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant. 2009 ; 24: 172-178
14. Moroni G, Radice A, Giammarresi G, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis. 2009 ; 68: 234-237
15. Coremans IE, Spronk PE, Bootsma H, et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis. 1995 ; 26: 595-601
16. Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus. 2011 ; 20: 1267-1274
17. Grootscholten C, Dieker JW, McGrath FD, et al. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann Rheum Dis. 2007 ; 66: 693-696
18. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 ; 64: 2677-2686
19. Martensson U, Sjöholm AG, Sturfelt G, Truedsson L, Laurell AB. Western blot analysis of human IgG reactive with the collagenous portion of C1q: Evidence of distinct binding specificities. Scand J Immunol. 1992 ; 35: 735-744
20. Antes U, Heinz HP, Loos M. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 1988 ; 31: 457-64
21. Wener MH, Uwatoko S, Mannik M. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum. 1989 ; 32: 544-551
22. Jonsson G, Sjöholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology (Oxford). 2007 ; 46: 1133-1139
23. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 ; 64: 2677-2686
24. Horváth L, Czirják L, Fekete B, et al. Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett. 2001 ; 75: 103-109
25. Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol. 2003 ; 30: 1495-1504
26. Sinico RA, Radice A, Ikehata M, et al. Anti-C1q autoantibodies in lupus nephritis: Prevalence and clinical significance. Ann N Y Acad Sci. 2005 ; 1050: 193-200
27. Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Clin Rheumatol. 2011 ; 30: 967-973
28. Yang XW, Tan Y, Yu F, Zhao MH. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Nephrol Dial Transplant. 2012 ; 27: 3552-3559
29. Braun A, Sis J, Max R, et al. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand J Rheumatol. 2007 ; 36: 291-298
30. Trad B, Ben Hassine H, Khalifa M, et al. Anti-C1q antibodies and systemic lupus erythematosus in the Tunisian population. Patho Biol (Paris). 2013 ; 61: 113-116
31. Seelen MA, Trouw LA, Daha MR. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr Opin Nephrol Hypertens. 2003 ; 12: 619-624
32. Heinlen LD, McClain MT, Merrill J, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum. 2007 ; 56: 2344-2351
33. Siegert CE, Daha MR, Swaak AJ, van der Voort EA, Breedveld FC. The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1993 ; 67: 204-209
34. Bələnescu E, Tənəsescu C, Bələnescu P, et al. Anti C1q antibodies in cutaneous lupus erythematosus. Rom J Intern Med. 2010 ; 48: 159-163